The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Tandem high-dose chemotherapy and autologous hematopoietic stem cell transplantation (SCT) compared to single SCT for relapsed/refractory germ cell tumors (GCT).
 
Deepak Kilari
No Relationships to Disclose
 
Parameswaran Hari
Honoraria - Amgen; Celgene; Millennium; Novartis; Sanofi; Spectrum Pharmaceuticals
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Onyx; Sanofi; Spectrum Pharmaceuticals; Takeda
Research Funding - Celgene (Inst); Millennium (Inst); Onyx (Inst); Spectrum Pharmaceuticals (Inst)
 
Muna Qayed
No Relationships to Disclose
 
Raphael Fraser
No Relationships to Disclose
 
Omar Davila
No Relationships to Disclose
 
Shaji Kumar
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Takeda (Inst)
Research Funding - Abbvie (Inst); Celgene (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Sanofi (Inst); Takeda (Inst)
 
Tomer Martin Mark
No Relationships to Disclose
 
Yago Nieto
No Relationships to Disclose
 
Anita D'Souza
Honoraria - North American Center for Continuing Medical Education
Research Funding - Merck; Prothena